What is included in the evaluation of a brief resolved unexplained event (BRUE) (apparent life-threatening event) (ALTE) in symptomatic or non-low-risk infants?

1. National Institute of Health. Infantile apnea and home monitoring. Natl Inst Health Consens Dev Conf Consens Statement. 1986 Oct 1. 6(6):1-10. [Medline].

2. Tieder JS, Bonkowsky JL, Etzel RA, et al. Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants. Pediatrics. 2016. 137(5):e20160590.

3. Frellick M. New AAP Guideline: Brief Unexplained Events in Infants. Medscape Medical News. Available at http://www.medscape.com/viewarticle/862390. April 25, 2016; Accessed: April 26, 2016.

4. Brooks JG. Apparent life-threatening events and apnea of infancy. Clin Perinatol. 1992 Dec. 19(4):809-38. [Medline].

5. McGovern MC, Smith MB. Causes of apparent life threatening events in infants: a systematic review. Arch Dis Child. 2004 Nov. 89(11):1043-8. [Medline].

6. Kiechl-Kohlendorfer U, Hof D, Peglow UP, Traweger-Ravanelli B, Kiechl S. Epidemiology of apparent life threatening events. Arch Dis Child. 2005 Mar. 90(3):297-300. [Medline].

7. Esani N, Hodgman J, Ehsani N, Hoppenbrousers T. Apparent Life-Threatening Events and Sudden Infant Death Syndrome: A Comparison of RIsk Factors. Journal of Pediatrics. March 2008. 152:365-70. [Medline].

8. Davies F, Gupta R. Apparent life threatening events in infants presenting to an emergency department. Emerg Med J. 2002 Jan. 19(1):11-6. [Medline].

9. Parker K, Pitetti R. Mortality and child abuse in children presenting with apparent life-threatening events. Pediatr Emerg Care. 2011 Jul. 27(7):591-5. [Medline].

10. Hasenstab KA, Jadcherla SR. Respiratory events in infants presenting with apparent life threatening events: is there an explanation from esophageal motility?. J Pediatr. 2014 Aug. 165(2):250-255.e1. [Medline]. [Full Text].

11. Nationwide Children's Hospital. Esophageal function implicated in life-threatening experiences in infants, study suggests. ScienceDaily. Available at http://www.sciencedaily.com/releases/2014/03/140328075732.htm. Accessed: October 3, 2014.

12. Altman RL, Forman S, Brand DA. Ophthalmologic findings in infants after an apparent life-threatening event. Eur J Ophthalmol. 2007 Jul-Aug. 17(4):648-53. [Medline].

13. Altman RL, Li KI, Brand DA. Infections and apparent life-threatening events. Clin Pediatr (Phila). 2008 May. 47(4):372-8. [Medline].

14. Zuckerbraun NS, Zomorrodi A, Pitetti RD. Occurrence of serious bacterial infection in infants aged 60 days or younger with an apparent life-threatening event. Pediatr Emerg Care. 2009 Jan. 25(1):19-25. [Medline].

15. Fu LY, Moon RY. Apparent life-threatening events: an update. Pediatr Rev. 2012 Aug. 33(8):361-8; quiz 368-9. [Medline].

16. Pitetti RD, Lovallo A, Hickey R. Prevalence of anemia in children presenting with apparent life-threatening events. Acad Emerg Med. 2005 Oct. 12(10):926-31. [Medline].

17. Hoki R, Bonkowsky JL, Minich LL, Srivastava R, Pinto NM. Cardiac testing and outcomes in infants after an apparent life-threatening event. Arch Dis Child. 2012 Dec. 97(12):1034-8. [Medline].

18. Takahashi T, Yamada K, Kobayashi H, Hasegawa Y, Taketani T, Fukuda S, et al. Metabolic disease in 10 patients with sudden unexpected death in infancy or acute life-threatening events. Pediatr Int. 2015 Jun. 57 (3):348-53. [Medline].

19. Doshi A, Bernard-Stover L, Kuelbs C, Castillo E, Stucky E. Apparent life-threatening event admissions and gastroesophageal reflux disease: the value of hospitalization. Pediatr Emerg Care. 2012 Jan. 28(1):17-21. [Medline].

20. Mittal MK, Sun G, Baren JM. A clinical decision rule to identify infants with apparent life-threatening event who can be safely discharged from the emergency department. Pediatr Emerg Care. 2012 Jul. 28(7):599-605. [Medline].

21. Kaji AH, Claudius I, Santillanes G, Mittal MK, Hayes K, Lee J, et al. Apparent Life-Threatening Event: Multicenter Prospective Cohort Study to Develop a Clinical Decision Rule for Admission to the Hospital. Ann Emerg Med. 2012 Sep 28. [Medline].

22. Claudius I, Keens T. Do all infants with apparent life-threatening events need to be admitted?. Pediatrics. 2007 Apr. 119(4):679-83. [Medline].

23. Brand DA, Altman RL, Purtill K, Edwards KS. Yield of diagnostic testing in infants who have had an apparent life-threatening event. Pediatrics. 2005 Apr. 115(4):885-93. [Medline].

24. Cote A. Home and hospital monitoring for ALTE. Paediatr Respir Rev. 2006. 7 Suppl 1:S199-201. [Medline].

25. Dewolfe CC. Apparent life-threatening event: a review. Pediatr Clin North Am. 2005 Aug. 52(4):1127-46, ix. [Medline].

26. Edner A, Wennborg M, Alm B, Lagercrantz H. Why do ALTE infants not die in SIDS?. Acta Paediatr. 2007 Feb. 96(2):191-4. [Medline].

27. Fu LY, Moon RY. Apparent life-threatening events (ALTEs) and the role of home monitors. Pediatr Rev. 2007 Jun. 28(6):203-8. [Medline].

28. Hall KL, Zalman B. Evaluation and management of apparent life-threatening events in children. Am Fam Physician. 2005 Jun 15. 71(12):2301-8. [Medline].

29. McCormick T, Levine M, Knox O, Claudius I. Ethanol Ingestion in Two Infants Under 2 Months Old: A Previously Unreported Cause of ALTE. Pediatrics. 2013 Jan 14. [Medline].

30. Miyagawa T, Sotero M, Avellino AM, et al. Apnea caused by mesial temporal lobe mass lesions in infants: report of 3 cases. J Child Neurol. 2007 Sep. 22(9):1079-83. [Medline].

31. Naulaers G, Daniels H, Allegaert K, Rayyan M, Debeer A, Devlieger H. Cardiorespiratory events recorded on home monitors: the effect of prematurity on later serious events. Acta Paediatr. 2007 Feb. 96(2):195-8. [Medline].

32. Reix P, St-Hilaire M, Praud JP. Laryngeal sensitivity in the neonatal period: from bench to bedside. Pediatr Pulmonol. 2007 Aug. 42(8):674-82. [Medline].

33. Semeniuk J, Kaczmarski M, Wasilewska J, Nowowiejska B. Is acid gastroesophageal reflux in children with ALTE etiopathogenetic factor of life threatening symptoms?. Adv Med Sci. 2007. 52:213-21. [Medline].

34. Shah S, Sharieff GQ. An update on the approach to apparent life-threatening events. Curr Opin Pediatr. 2007 Jun. 19(3):288-94. [Medline].

35. Warren J, Biagioli F, Hamilton A, Smith PC. FPIN's clinical inquiries. Evaluation of apparent life-threatening events in infants. Am Fam Physician. 2007 Jul 1. 76(1):124-6. [Medline].

36. Waseem M, Pinkert H. Apparent life-threatening event or child abuse?. Pediatr Emerg Care. 2006 Apr. 22(4):245-6. [Medline].

37. Zimbric G, Bonkowsky JL, Jackson WD, Maloney CG, Srivastava R. Adverse outcomes associated with gastroesophageal reflux disease are rare following an apparent life-threatening event. J Hosp Med. 2012 Jul-Aug. 7(6):476-81. [Medline].

38. Zuckerbraun NS, Zomorrodi A, Pitetti RD. Occurrence of serious bacterial infection in infants aged 60 days or younger with an apparent life-threatening event. Pediatr Emerg Care. 2009 Jan. 25(1):19-25. [Medline].

39. Tieder JS, Altman RL, Bonkowsky JL, Brand DA, Claudius I, Cunningham DJ, et al. Management of apparent life-threatening events in infants: a systematic review. J Pediatr. 2013 Jul. 163 (1):94-9.e1-6. [Medline].

40. Monti MC, Borrelli P, Nosetti L, Tajè S, Perotti M, Bonarrigo D, et al. Incidence of apparent life-threatening events and post-neonatal risk factors. Acta Paediatr. 2017 Feb. 106 (2):204-210. [Medline].

41. Doughty K, Rood C, Patel A, Thackeray JD, Brink FW. Neurological Manifestations of Medical Child Abuse. Pediatr Neurol. 2016 Jan. 54:22-8. [Medline].

42. Tieder JS, Altman RL, Bonkowsky JL, Brand DA, Claudius I, Cunningham DJ, et al. Management of apparent life-threatening events in infants: a systematic review. J Pediatr. 2013 Jul. 163 (1):94-9.e1-6. [Medline].

43. Ueda R, Nomura O, Maekawa T, Sakai H, Nakagawa S, Ishiguro A. Independent risk factors for recurrence of apparent life-threatening events in infants. Eur J Pediatr. 2017 Apr. 176 (4):443-448. [Medline].

44. McFarlin A. What to Do when Babies Turn Blue: Beyond the Basic Brief Resolved Unexplained Event. Emerg Med Clin North Am. 2018 May. 36 (2):335-347. [Medline].

45. Brand DA, Mock A, Cohn E, Krilov LR. Implementing the 2016 American Academy of Pediatrics Guideline on Brief Resolved Unexplained Events: The Parent's Perspective. Pediatr Emerg Care. 2018 Nov 5. [Medline].

46. Tieder JS. Mortality Risk and Hospital Admission after a Brief Resolved Unexplained Event. J Pediatr. 2018 Jun. 197:12-13. [Medline].

47. Brand DA, Fazzari MJ. Risk of Death in Infants Who Have Experienced a Brief Resolved Unexplained Event: A Meta-Analysis. J Pediatr. 2018 Jun. 197:63-67. [Medline].

48. Triemstra J. The Cost of Hospital Admission: Brief Resolved Unexplained Events. Pediatr Ann. 2017 Jul 1. 46 (7):e262-e264. [Medline].

Patrick L Carolan, MD Adjunct Associate Professor, Departments of Pediatrics, Family Practice, and Community Health, University of Minnesota Medical School; Medical Director of Minnesota Sudden Infant Death Center; Attending Staff, Department of Emergency Services, Children's Hospitals and Clinics of Minnesota

Patrick L Carolan, MD is a member of the following medical societies: American Academy of Pediatrics, International Society for the Study and Prevention of Perinatal and Infant Death

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Girish D Sharma, MD, FCCP, FAAP Professor of Pediatrics, Rush Medical College; Director, Section of Pediatric Pulmonology and Rush Cystic Fibrosis Center, Rush Children's Hospital, Rush University Medical Center

Girish D Sharma, MD, FCCP, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, Royal College of Physicians of Ireland

Disclosure: Nothing to disclose.

Susanna A McColley, MD Professor of Pediatrics, Northwestern University, The Feinberg School of Medicine; Director of Cystic Fibrosis Center, Head, Division of Pulmonary Medicine, Children's Memorial Medical Center of Chicago

Susanna A McColley, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Sleep Disorders Association, American Thoracic Society

Disclosure: Received honoraria from Genentech for speaking and teaching; Received honoraria from Genentech for consulting; Partner received consulting fee from Boston Scientific for consulting; Received honoraria from Gilead for speaking and teaching; Received consulting fee from Caremark for consulting; Received honoraria from Vertex Pharmaceuticals for speaking and teaching.